During the past five years, the reality of the cannabis industry has not lived up to the hype that accompanied Canada's ...

During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

The global cannabis and hemp market is experiencing dynamic changes driven by several factors. Growing consumer awareness about the therapeutic benefits ...

There could be progress on the cannabis legalization front in the next five years. Whether Tilray benefits from this will depend on a lot of factors. The company's outlook remains risky and uncertain.

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

Cannabis stocks have largely generated abysmal returns during much of that time. Tilray Brands (NASDAQ: TLRY), a leader in the sector, is no exception. However, the company has made significant ...

Trudeau's legalization legacy shaped Canada's global cannabis leadership. Conservative leadership risks policy stagnation & economic setbacks; publicly traded weed companies face uncertainty amid ...

One of the top cannabis stocks in the industry is Tilray Brands (TLRY-3.51%), and during that stretch, its valuation has crumbled, falling by a staggering 94%. The Canada-based company has been ...

In a challenging market environment, Tilray Inc (NASDAQ:TLRY) stock has reached a 52-week low, dipping to $1.06. The cannabis company, which has been navigating through regulatory hurdles and intense ...